Huangshan Novel Co Ltd (002014) - Net Assets

Latest as of September 2025: CN¥2.39 Billion CNY ≈ $350.17 Million USD

Based on the latest financial reports, Huangshan Novel Co Ltd (002014) has net assets worth CN¥2.39 Billion CNY (≈ $350.17 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.17 Billion ≈ $610.32 Million USD) and total liabilities (CN¥1.78 Billion ≈ $260.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Huangshan Novel Co Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥2.39 Billion
% of Total Assets 57.38%
Annual Growth Rate 15.66%
5-Year Change 29.79%
10-Year Change 61.49%
Growth Volatility 30.51

Huangshan Novel Co Ltd - Net Assets Trend (2001–2024)

This chart illustrates how Huangshan Novel Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 002014 total assets for the complete picture of this company's asset base.

Annual Net Assets for Huangshan Novel Co Ltd (2001–2024)

The table below shows the annual net assets of Huangshan Novel Co Ltd from 2001 to 2024. For live valuation and market cap data, see 002014 market cap.

Year Net Assets Change
2024-12-31 CN¥2.64 Billion
≈ $385.81 Million		 +5.26%
2023-12-31 CN¥2.50 Billion
≈ $366.52 Million		 +7.74%
2022-12-31 CN¥2.32 Billion
≈ $340.19 Million		 +7.06%
2021-12-31 CN¥2.17 Billion
≈ $317.75 Million		 +6.89%
2020-12-31 CN¥2.03 Billion
≈ $297.27 Million		 +7.19%
2019-12-31 CN¥1.90 Billion
≈ $277.32 Million		 +1.18%
2018-12-31 CN¥1.87 Billion
≈ $274.10 Million		 +4.27%
2017-12-31 CN¥1.80 Billion
≈ $262.87 Million		 +2.31%
2016-12-31 CN¥1.76 Billion
≈ $256.92 Million		 +7.54%
2015-12-31 CN¥1.63 Billion
≈ $238.90 Million		 +4.62%
2014-12-31 CN¥1.56 Billion
≈ $228.36 Million		 +3.61%
2013-12-31 CN¥1.51 Billion
≈ $220.41 Million		 +6.50%
2012-12-31 CN¥1.41 Billion
≈ $206.96 Million		 +63.30%
2011-12-31 CN¥866.09 Million
≈ $126.74 Million		 +12.35%
2010-12-31 CN¥770.86 Million
≈ $112.80 Million		 +10.35%
2009-12-31 CN¥698.53 Million
≈ $102.22 Million		 +10.93%
2008-12-31 CN¥629.71 Million
≈ $92.15 Million		 +6.75%
2007-12-31 CN¥589.90 Million
≈ $86.32 Million		 +57.22%
2006-12-31 CN¥375.21 Million
≈ $54.91 Million		 +3.26%
2005-12-31 CN¥363.37 Million
≈ $53.17 Million		 +4.46%
2004-12-31 CN¥347.85 Million
≈ $50.90 Million		 +140.65%
2003-12-31 CN¥144.55 Million
≈ $21.15 Million		 +29.61%
2002-12-31 CN¥111.53 Million
≈ $16.32 Million		 +20.22%
2001-12-31 CN¥92.77 Million
≈ $13.58 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Huangshan Novel Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6556.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.20 Billion 46.48%
Common Stock CN¥612.49 Million 23.65%
Other Comprehensive Income CN¥263.79 Million 10.19%
Other Components CN¥509.58 Million 19.68%
Total Equity CN¥2.59 Billion 100.00%

Huangshan Novel Co Ltd Competitors by Market Cap

The table below lists competitors of Huangshan Novel Co Ltd ranked by their market capitalization.

Company Market Cap
Ningxia Western Venture Industrial Co Ltd
SHE:000557
 $1.00 Billion
BW Offshore Ltd
OL:BWO
 $1.00 Billion
Yuanta Futures Co Ltd
TWO:6023
 $1.00 Billion
Altri SGPS SA
LS:ALTR
 $1.00 Billion
Valeura Energy Inc
TO:VLE
 $1.00 Billion
Lenzing Aktiengesellschaft
VI:LNZ
 $1.00 Billion
Clover Health Investments Corp
NASDAQ:CLOV
 $1.00 Billion
GRIPM Advanced Materials Co. Ltd. A
SHG:688456
 $1.00 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Huangshan Novel Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,457,510,947 to 2,589,272,188, a change of 131,761,241 (5.4%).
  • Net income of 467,752,894 contributed positively to equity growth.
  • Dividend payments of 347,748,569 reduced retained earnings.
  • Other comprehensive income increased equity by 261,296,146.
  • Other factors decreased equity by 249,539,230.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥467.75 Million +18.07%
Dividends Paid CN¥347.75 Million -13.43%
Other Comprehensive Income CN¥261.30 Million +10.09%
Other Changes CN¥-249.54 Million -9.64%
Total Change CN¥- 5.36%

Book Value vs Market Value Analysis

This analysis compares Huangshan Novel Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.66x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 45.20x to 2.66x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-12-31 CN¥0.25 CN¥11.19 x
2002-12-31 CN¥0.30 CN¥11.19 x
2003-12-31 CN¥0.39 CN¥11.19 x
2004-12-31 CN¥0.91 CN¥11.19 x
2005-12-31 CN¥0.95 CN¥11.19 x
2006-12-31 CN¥0.84 CN¥11.19 x
2007-12-31 CN¥1.26 CN¥11.19 x
2008-12-31 CN¥1.24 CN¥11.19 x
2009-12-31 CN¥1.37 CN¥11.19 x
2010-12-31 CN¥1.51 CN¥11.19 x
2011-12-31 CN¥1.68 CN¥11.19 x
2012-12-31 CN¥2.60 CN¥11.19 x
2013-12-31 CN¥2.52 CN¥11.19 x
2014-12-31 CN¥2.60 CN¥11.19 x
2015-12-31 CN¥2.68 CN¥11.19 x
2016-12-31 CN¥2.84 CN¥11.19 x
2017-12-31 CN¥2.93 CN¥11.19 x
2018-12-31 CN¥3.06 CN¥11.19 x
2019-12-31 CN¥3.11 CN¥11.19 x
2020-12-31 CN¥3.23 CN¥11.19 x
2021-12-31 CN¥3.50 CN¥11.19 x
2022-12-31 CN¥3.77 CN¥11.19 x
2023-12-31 CN¥4.04 CN¥11.19 x
2024-12-31 CN¥4.21 CN¥11.19 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Huangshan Novel Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 18.07%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 13.27%
  • • Asset Turnover: 0.82x
  • • Equity Multiplier: 1.67x
  • Recent ROE (18.07%) is above the historical average (15.35%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 22.93% 8.61% 1.32x 2.02x CN¥11.99 Million
2002 31.69% 9.86% 1.62x 1.99x CN¥24.19 Million
2003 29.58% 9.92% 1.69x 1.76x CN¥28.31 Million
2004 12.83% 9.00% 1.01x 1.41x CN¥9.64 Million
2005 12.38% 7.22% 1.24x 1.38x CN¥8.49 Million
2006 12.91% 6.57% 1.27x 1.54x CN¥10.66 Million
2007 9.31% 5.15% 1.24x 1.46x CN¥-4.01 Million
2008 11.05% 5.58% 1.34x 1.48x CN¥6.48 Million
2009 14.72% 9.55% 1.08x 1.43x CN¥32.30 Million
2010 16.15% 9.50% 1.16x 1.47x CN¥46.15 Million
2011 17.53% 9.77% 1.15x 1.56x CN¥63.50 Million
2012 12.86% 11.75% 0.83x 1.32x CN¥39.75 Million
2013 11.89% 10.89% 0.85x 1.28x CN¥28.00 Million
2014 10.04% 9.26% 0.85x 1.28x CN¥685.42K
2015 11.83% 10.28% 0.89x 1.29x CN¥29.38 Million
2016 11.74% 10.65% 0.84x 1.32x CN¥30.04 Million
2017 11.65% 10.23% 0.84x 1.36x CN¥29.06 Million
2018 12.26% 9.66% 0.92x 1.38x CN¥41.48 Million
2019 14.48% 10.35% 1.02x 1.37x CN¥83.32 Million
2020 15.22% 11.07% 0.93x 1.48x CN¥103.92 Million
2021 14.84% 10.45% 1.00x 1.41x CN¥103.05 Million
2022 15.92% 10.98% 0.92x 1.57x CN¥134.96 Million
2023 16.60% 12.08% 0.87x 1.59x CN¥162.29 Million
2024 18.07% 13.27% 0.82x 1.67x CN¥208.83 Million

Industry Comparison

This section compares Huangshan Novel Co Ltd's net assets metrics with peer companies in the Packaging & Containers industry.

Industry Context

  • Industry: Packaging & Containers
  • Average net assets among peers: $2,252,146,275
  • Average return on equity (ROE) among peers: 1.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Huangshan Novel Co Ltd (002014) CN¥2.39 Billion 22.93% 0.74x $1.00 Billion
Zhuhai Zhongfu Enterprise Co Ltd (000659) $2.42 Billion 2.89% 1.12x $758.20 Million
Shenzhen Jinjia Color Printing Group Co Ltd (002191) $4.37 Billion 16.48% 0.23x $805.15 Million
Xiamen Hexing Packaging Printing Co Ltd (002228) $830.41 Million 8.56% 0.96x $692.47 Million
Shenzhen Beauty Star Co Ltd (002243) $128.26 Million 25.54% 1.46x $1.51 Billion
Zhejiang Great Southeast Co Ltd (002263) $2.79 Billion -6.65% 0.42x $1.11 Billion
Shenzhen MYS Environmental Protection & Technology Co Ltd (002303) $4.97 Billion 2.71% 0.49x $761.87 Million
Shandong Lipeng Co Ltd (002374) $1.32 Billion -51.89% 1.91x $511.34 Million
Zhejiang Zhongcheng Packing Material Co Ltd (002522) $1.36 Billion 4.42% 0.28x $841.65 Million
Shanghai Luxin Packing Materials Science&Technology Co Ltd (002565) $2.06 Billion 11.10% 0.50x $2.95 Billion

About Huangshan Novel Co Ltd

SHE:002014 China Packaging & Containers
Market Cap
$1.00 Billion
CN¥6.85 Billion CNY
Market Cap Rank
#9098 Global
#2436 in China
Share Price
CN¥11.19
Change (1 day)
-0.80%
52-Week Range
CN¥10.73 - CN¥12.81
All Time High
CN¥12.81
Categories
Companies in China Packaging & Containers
About

Huangshan Novel Co.,Ltd manufactures and sells packaging materials in China and internationally. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials. Its products are used in food, dairy, pet food, daily chemicals, pharmaceutical, a… Read more